Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 04, 2025 09:00 ET | Source: Optigo Biotherapeutics Inc.

Renowned Pharma and Biotech Development Leader, Dr. Andreas Wallnöfer, is named to Optigo Biotherapeutics’ Board of Directors as the company advances to IND-enabling studies

Dr. Andreas Wallnöfer joins the board of Optigo Biotherapeutics – the ophthalmology company pioneering next-gen treatments for retinal diseases.
October 20, 2025 16:35 ET | Source: Bio Usawa Inc

Bio Usawa Announces Approval of BioUcenta™ by the Rwandan FDA

KIGALI, Rwanda and SAN FRANCISCO, Oct. 20, 2025 (GLOBE NEWSWIRE) -- The Rwanda Food and Drugs Authority has granted market approval for Bio Usawa Biotechnology Ltd.’s (Bio Usawa) BioUcenta™, a...
July 28, 2025 07:15 ET | Source: Bio Usawa Inc

Bio Usawa Biotechnology (Bio Usawa) Partners with DEK Vaccines Ltd (DEK) to Expand Access to Life-Saving Biopharmaceuticals Across Ghana and West Africa

KIGALI, Rwanda and SAN FRANCISCO and ACCRA, Ghana , July 28, 2025 (GLOBE NEWSWIRE) -- Bio Usawa, a pioneering private biotechnology company committed to developing and manufacturing affordable,...
July 10, 2025 13:27 ET | Source: Spherix Global Insights

Biologic Competition, Payer Pressures, and Gene Therapy Momentum Define a Pivotal Moment in nAMD and DME Management, According to Spherix Global Insights

Exton, Pennsylvania, July 10, 2025 (GLOBE NEWSWIRE) -- Recently released research from Spherix Global Insights provides a timely look at the increasingly competitive and complex treatment landscape...
July 01, 2025 07:15 ET | Source: Bio Usawa Inc

Bio Usawa Biotechnology and Bioeq AG Partner to Create Widespread Access to Vision-Saving Medicine Across Sub-Saharan Africa

Bio Usawa Biotechnology Ltd. and Bioeq AG today announced a partnership to bring a life-changing biosimilar of ranibizumab to Sub-Saharan Africa.
May 26, 2025 10:56 ET | Source: Research and Markets

U.S. Ophthalmic Photocoagulator Growth Trends and Forecasts 2025-2032 - Market Expands Amid Surge in Diabetic Retinopathy Cases

Dublin, May 26, 2025 (GLOBE NEWSWIRE) -- The "U.S. Ophthalmic Photocoagulator Market - Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032 - By Product, Technology, Grade, Application,...
May 08, 2025 16:05 ET | Source: Oculis Holding AG

Oculis Reports Q1 2025 Financial Results and Provides Company Update

The recent R&D Day (replay) showcased material progress across all three core assets and highlighted potential first-in-class neuroprotection treatment in neuro-ophthalmology, an area of high...
May 07, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Present at Upcoming May Investor Conferences

ZUG, Switzerland, May 07, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and...
May 06, 2025 20:00 ET | Source: Optigo Biotherapeutics Inc.

Optigo Biotherapeutics Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at the ARVO 2025 Conference

Optigo Bio Wins People’s Choice Award at Eyecelerator and Presents Compelling Preclinical Data on Long-Acting Intravitreal Biologics at ARVO 2025
May 01, 2025 04:00 ET | Source: Oculis Holding AG

Oculis to Present its Innovative Late-Stage Pipeline Candidates at Upcoming Ophthalmology Conferences

ZUG, Switzerland, May 01, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / ICX: OCS.IC) (“Oculis”), a global biopharmaceutical company focused on innovations addressing ophthalmic and...